Kim Byung-Gun, Jeon Young-Tae, Han Jiwon, Bae Yu Kyung, Lee Si Un, Ryu Jung-Hee, Koo Chang-Hoon
Department of Anesthesiology and Pain Medicine, Inha University School of Medicine, Inha University Hospital, Incheon 22332, Korea.
Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
J Clin Med. 2021 Mar 12;10(6):1197. doi: 10.3390/jcm10061197.
Although thiopental improved neurological outcomes in several animal studies, there are still insufficient clinical data examining the efficacy of thiopental for patients undergoing surgical clipping of unruptured intracranial aneurysm (UIA). This study validated the effect of thiopental and investigated risk factors associated with postoperative neurological complications in patients undergoing surgical clipping of UIA. In total, 491 patients who underwent aneurysm clipping were included in this retrospective cohort study. Data regarding demographics, aneurysm characteristics, and use of thiopental were collected from electronic medical records. Propensity score matching and logistic regression analysis were used. After propensity score matching, the thiopental group showed a lower incidence of the postoperative neurological complications than non-thiopental group (5.5% vs. 17.1%, = 0.001). In multivariate analysis, thiopental reduced the risk of postoperative neurological complications (odds ratio (OR) 0.26, 95% confidence interval (CI) 0.13 to 0.51, < 0.001) while aneurysm size ≥ 10 mm (OR 4.48, 95% CI 1.69 to 11.87, = 0.003), and hyperlipidemia (OR 2.24, 95% CI 1.16 to 4.32, = 0.02) increased the risk of postoperative neurological complications. This study showed that thiopental was associated with the lower risk of neurological complications after clipping of UIA.
尽管硫喷妥钠在多项动物研究中改善了神经学预后,但仍缺乏足够的临床数据来检验硫喷妥钠对未破裂颅内动脉瘤(UIA)手术夹闭患者的疗效。本研究验证了硫喷妥钠的效果,并调查了UIA手术夹闭患者术后神经并发症的相关危险因素。本回顾性队列研究共纳入491例行动脉瘤夹闭术的患者。从电子病历中收集了人口统计学、动脉瘤特征和硫喷妥钠使用情况的数据。采用倾向评分匹配和逻辑回归分析。倾向评分匹配后,硫喷妥钠组术后神经并发症的发生率低于非硫喷妥钠组(5.5%对17.1%,P = 0.001)。在多变量分析中,硫喷妥钠降低了术后神经并发症的风险(比值比(OR)0.26,95%置信区间(CI)0.13至0.51,P < 0.001),而动脉瘤大小≥10 mm(OR 4.48,95%CI 1.69至11.87,P = 0.003)和高脂血症(OR 2.24,95%CI 1.16至4.32,P = 0.02)增加了术后神经并发症的风险。本研究表明,硫喷妥钠与UIA夹闭术后较低的神经并发症风险相关。